Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22307534 | 0.91 | SMN1; SMN2 (0.46) | LMNASMN1; SMN2KDM4ETP53ALDH1A1 | |
| SCHEMBL12088221 | 0.90 | CNR2 (0.46) | LMNASMN1; SMN2KDM4ETP53ALDH1A1 | |
| SCHEMBL17858617 | 0.85 | SMN1; SMN2 (0.44) | LMNASMN1; SMN2KDM4EALDH1A1CNR2 | |
| SCHEMBL9331718 | 0.82 | SMN1; SMN2 (0.51) | LMNASMN1; SMN2KDM4ETP53ALDH1A1 | |
| SCHEMBL11829279 | 0.81 | NAAA (0.45) | SMN1; SMN2KDM4ETP53CNR2HTT | |
| SCHEMBL11836308 | 0.80 | NAAA (0.51) | LMNASMN1; SMN2KDM4ETP53ALDH1A1 | |
| SCHEMBL10908408 | 0.79 | ALDH1A1 (0.44) | LMNASMN1; SMN2ALDH1A1KMT2A | |
| SCHEMBL7931309 | 0.78 | TSHR (0.48) | NR1I2SMN1; SMN2KDM4ECNR2HTT | |
| SCHEMBL6212788 | 0.77 | SMN1; SMN2 (0.45) | LMNASMN1; SMN2KDM4ETP53ALDH1A1 | |
| SCHEMBL12088208 | 0.77 | DNM1 (0.59) | LMNASMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230205083-A1 | SALT COMPOUND, RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230205083-A1 | SALT COMPOUND, RESIST COMPOSITION AND PATTERNING PROCESS | SLC6A9, SLC6A5, REN | NR1I2 1797/4885LMNA 2393/4885SMN1; SMN2 3295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.